Die rolle der anthrazykline beim metastasierten mammakarzinom

Translated title of the contribution: The role of anthracyclines in the treatment of metastatic breast cancer

Research output: Contribution to journalReview articlepeer-review

Abstract

Anthracyclines are among the most active agents in the treatment of metastatic breast cancer. Anthracycline-containing chemotherapy may even result in long-term survival in some patients who achieve a complete response. Anthracycline combinations have been shown to be superior to single-agent anthracyclines, and dose-intensive regimens to be more effective than standard-dose regimens. Epirubicin is nearly as effective as doxorubicin, but with significantly reduced toxicity. Recent results indicate that the efficacy of chemotherapy may be further enhanced by the combination of anthracyclines with taxanes.

Translated title of the contributionThe role of anthracyclines in the treatment of metastatic breast cancer
Original languageGerman
Pages (from-to)12-14
Number of pages3
JournalOnkologie
Volume23
Issue numberSUPPL. 2
StatePublished - Apr 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'The role of anthracyclines in the treatment of metastatic breast cancer'. Together they form a unique fingerprint.

Cite this